BUY
He added to it recently at about $20. It is consolidating the pharmaceutical business in rural areas. It also helps boost front store sales. The scope of work done by pharmacists is increasing and therefore providing good growth opportunities.
Healthcare
TOP PICK
It is the third largest pharmacy chain in Canada. Is mostly in the rural communities and has a strategy to consolidate the fragmented industry in these areas and grow the top line. It is both a defensive and a growth stock. It has new revenue sources since pharrmacies can prescribe more medications now as well as offer more services. After its IPO 18 months ago, it soared then fell back to the low $20's, close to its IPO price. Had very good results a few weeks ago. It has doubled its revenue to $830 and EBITA to $100. Has good free cash flow and increased margins. There has been significant insider buying in the past few months. A safe way to play the health care system. Buy 6, Hold 3, Sell 0 (Analysts’ price target is $29.56)
Healthcare
TOP PICK
Small cap, but it's grown. Fantastic opportunity to consolidate rural drugstores in the Prairies. Growth by acquisition. Margins are incredibly good. Poised to outperform. Defensive, and pharmacies are providing more and more services. Yield is 0.70%. (Analysts’ price target is $37.83)
Healthcare
WAIT

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. There is no news that would change fundamentals. It is trading at 48x earnings, so it is expensive and the market is not liking high valuation names right now. Would not buy on the negative momentum. Wait for confirmation of an uptrend before considering. Unlock Premium - Try 5i Free

Healthcare
BUY on WEAKNESS

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The revenues were short of estimates but the additional IPO cost is not surprising. New pharmacies are contributing to 55% revenue gains. The stock remains above IPO prices. Unlock Premium - Try 5i Free

Healthcare
Showing 1 to 5 of 5 entries
  • «
  • 1
  • »

Neighbourly Pharmacy Inc(NBLY-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Neighbourly Pharmacy Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Neighbourly Pharmacy Inc(NBLY-T) Frequently Asked Questions

What is Neighbourly Pharmacy Inc stock symbol?

Neighbourly Pharmacy Inc is a Canadian stock, trading under the symbol NBLY-T on the Toronto Stock Exchange (NBLY-CT). It is usually referred to as TSX:NBLY or NBLY-T

Is Neighbourly Pharmacy Inc a buy or a sell?

In the last year, 1 stock analyst published opinions about NBLY-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Neighbourly Pharmacy Inc.

Is Neighbourly Pharmacy Inc a good investment or a top pick?

Neighbourly Pharmacy Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Neighbourly Pharmacy Inc.

Why is Neighbourly Pharmacy Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Neighbourly Pharmacy Inc worth watching?

1 stock analyst on Stockchase covered Neighbourly Pharmacy Inc In the last year. It is a trending stock that is worth watching.

What is Neighbourly Pharmacy Inc stock price?

On 2023-01-27, Neighbourly Pharmacy Inc (NBLY-T) stock closed at a price of $19.84.